Increasing need for source data verification solutions in clinical trials and rising demand for cost-effective monitoring systems are driving the risk-based monitoring (RBM) software market. Market Size – USD 253.6 Million in 2019, Market Growth – at a CAGR of 13.1%, Market Trend – Rise in adoption of software solutions in clinical trials

The global size was USD 253.6 Million in 2019 and is expected to reach USD 644.6 Million by 2027, at a CAGR of 13.1% during the forecast period. The global risk-based monitoring (RBM) software market is expected to expand significantly during the forecast period, owing to the growing number of clinical trials worldwide. Rising demand for monitoring solutions to resolve issues during clinical trials is expected to drive the global risk-based monitoring (RBM) software market during the forecast period.

The latest market intelligence study on the Risk-based Monitoring (RBM) Software Market covers the performance of both the key vendors and new entrants for the forecast period, 2020 - 2027. Estimated value, profits, gross margin, spending power and consumption volume form an important part of the study that aims at offering the business owners, stakeholders, and marketing personnel a competitive edge over others. Importantly, the study discusses a lot about, the product application, classification and performance across different regions. The industry assessment report weighs upon the top performers and also the winning strategies that have enabled them to occupy a strong foothold in the Risk-based Monitoring (RBM) Software Market.

Read more@ https://www.emergenresearch.com/industry-report/risk-based-monitori...